Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Peter Barlis , Mun Hong Cheang , Carlo Di Mario Added: 3 years ago
In the past few decades, tremendous developments have been made in the field of interventional cardiology. The evolution of such tools as balloon angioplasty, bare-metal stents (BMS) and now drug-eluting stents (DES) has incrementally opened up new possibilities in the treatment of coronary artery disease and, correspondingly, an ever-decreasing need for invasive surgery. The most challenging… View more

Intervention
ISCP
The International Society of Cardiovascular Pharmacotherapy was created to support and promote ethical, evidence-based, cardiovascular pharmacotherapy worldwide. ISCP represents an ideal forum for open discussions on all issues related to cardiovascular pharmacotherapy and the society endeavours to foster collaboration among health professionals around the World. ISCP promotes education, research… View more
Job title: Head of Cardiac Electrophysiology
Prof. Széplaki graduated as an MD at the Semmelweis University, Budapest and later completed his PhD thesis in the field of atherosclerosis.He completed his cardiology training and later worked as a senior lecturer at the Heart and Vascular Centre, Semmelweis University before joining the Mater Private Hospital, Dublin. He also obtained a Diploma of Advanced Studies in Cardiac Arrhythmia… View more
EuroPCR 22: DECISION QFR Shows Increased Practicability and Shorter Procedure Time for Revasc.
Author(s): Taku Asano Added: 1 year ago
In this short interview, Dr Taku Asano (St. Luke's International Hospital, JP) outlines the findings of the DESCISION QFR trial at EuroPCR 2022. DESCISION QFR aimed to evaluate the feasibility of involving quantitative flow ratio based patient information to determine the optimal revascularization approach in patients with multivessel disease. The study met its primary endpoints, where… View more

Imaging & Diagnostics

Intervention
Job title: Associate Professor and Senior Physician
Prof Felix Mahfoud is an Associate Professor and senior physician of Internal Medicine and Cardiology at Saarland University Hospital, and Affiliate/Visiting Professor Harvard-MIT Biomedical Engineering, Institute of Medical Engineering and Science, Cambridge, US. Prof Mahfoud completed training in Cardiology and Interventional Cardiology at the Department for Internal Medicine III, Saarland… View more
Steven Yakubov
Job title: Director
Dr Yakubov is the John H. McConnell Chair of Advanced Structural Heart Disease, System Medial Chief, Advanced Structural Heart Disease of OhioHealth and Medical Director of Cardiovascular Studies for the OhioHealth Research Institute at Riverside Methodist Hospital, Columbus, Ohio. He has been involved in numerous clinical trials to advance treatment options for cardiovascular disease and… View more
Job title: Vascular Surgeon
Dr Kak Khee Yeung is a vascular surgeon at VU University Medical Center, Amsterdam. Her focus areas of treatment are dilating (aneurysm) and stenosing (narrowing) arterial disease with new treatment methods, in particular minimally invasive endovascular methods.She is also a Principal Investigator in research into aortic aneurysm and dissections and have been awarded the Dekker grant from the… View more
Author(s): Roberto Sciagrà Added: 3 years ago
The best possible outcome in acute myocardial infarction (AMI) is the absence of any residual myocardial damage. This condition, usually obtained by early and effective reperfusion therapy, has been defined as aborted infarction.1 The classic diagnosis of aborted infarction is based on the detection of a minimal increase in cardiac enzymes together with a favourable evolution of the… View more

Heart Failure
Author(s): Zuzana Kaifoszova , Petr Widimsky Added: 3 years ago
Primary percutaneous coronary intervention (PPCI) and thrombolysis (TL) represent two alternative reperfusion strategies for ST-elevation acute myocardial infarction (STEMI) patients. In many randomised clinical trials,1 PPCI has been shown to be superior to TL in reducing mortality, re-infarction and stroke. These benefits are linked with a much higher early mechanical reperfusion rate (90 %,… View more

MI/ACS

Intervention
Job title: Director
Dr AntonioP Gasparis is a Professor of Surgery, Director - Center for Vein Care, Medical Director at Non-Invasive Vascular Laboratory, Medical Director at Bellavie MedSpa, Director at Phlebology Fellowship - Stony Brook University Medical Center, Stony Brook, NY, US. Dr Gasparis obtained his medical degree from SUNY-Syracuse in 1996 and his residency in general surgery. Clinical Interests… View more